A Japanese conglomerate has found that anti-parasitic drug Ivermectin is effective and safe for the treatment of the COVID-19 Omicron variant according to a phase III clinical trial.
Federal health agencies haven’t recognized ivermectin as an effective treatment for COVID-19 patients. According to Doctor Leland Stillman, the reason is more political than scientific, because otherwise there would be no bases for lockdowns or vaccine mandates.